Identification and characterization of transcripts from the neurofibromatosis 1 region: The sequence and genomic structure of EVI2 and mapping of other transcripts

Richard M. Cawthon, Peter O'Connell, Arthur M. Buchberg, David Viskochil, Robert B. Weiss, Melanie Culver, Jeffrey Stevens, Nancy A. Jenkins, Neal G. Copeland, Ray White

Research output: Contribution to journalArticle

103 Scopus citations

Abstract

Mapping of the EVI2 gene between the translocation breakpoints of two patients with neurofibromatosis type 1 (NF1), combined with the likely role of its murine homolog in neoplastic disease, implicates EVI2 as a possible candidate for the NF1 gene. We report here the expression of a 1.6-kb EVI2 transcript in normal human brain and peripheral blood mononuclear cells. Sequencing studies predict an EVI2 protein of 232 amino acids that contains an N-terminal signal peptide, an extracellular domain with five potential glycosylation sites, a single hydrophobic transmembrane domain with a leucine zipper, and a hydrophilic cytoplasmic domain. These features are all well-conserved with respect to the mouse Evi-2 protein and are consistent with the hypothesis that EVI2 is a membrane protein that may complex with itself and/or other proteins within the membrane, perhaps to function as part of a cell-surface receptor. In the course of these studies we have also identified three other transcripts (classes of cDNAs) from the NF1 region. Two of these transcripts map between the NF1 translocation breakpoints; the remaining transcript maps just outside this region.

Original languageEnglish (US)
Pages (from-to)555-565
Number of pages11
JournalGenomics
Volume7
Issue number4
DOIs
StatePublished - Aug 1990

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Identification and characterization of transcripts from the neurofibromatosis 1 region: The sequence and genomic structure of EVI2 and mapping of other transcripts'. Together they form a unique fingerprint.

Cite this